Biltmore Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,252
Closed -$633K 51
2018
Q4
$633K Sell
3,252
-266
-8% -$51.9K 0.7% 18
2018
Q3
$729K Buy
+3,518
New +$693K 0.6% 19

Other funds holding AMGN

Biltmore Wealth Management's AMGN Position: Q1 2019 in Review

Biltmore Wealth Management sold out of Amgen (AMGN) in Q1 2019, closing a stake of 3,252 shares — an estimated $633K sold.

Biltmore Wealth Management first reported a position in AMGN in Q3 2018 and held it in 2 quarters. The position peaked at $729K in Q3 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Biltmore Wealth Management reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Biltmore Wealth Management sold 3,252 Amgen shares in Q1 2019, an estimated $633K.
  • Biltmore Wealth Management first reported a position in Amgen in Q3 2018 and held it in 2 quarters.
  • Biltmore Wealth Management's Amgen position peaked at $729K in Q3 2018.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Biltmore Wealth Management's 13F filing for Q1 2019, filed 8 Apr 2019.